Description

This course begins with an overview of general intellectual property law in the United States, then examines how the policy choices behind those laws shapes the behavior of major players in the healthcare industry. We will examine how patents and trademarks shape the behavior of pharmaceutical companies, and how complex issues involving medical research in university settings, and ownership of genetic information and material, are resolved by intellectual property laws. The course concludes with in-depth case studies of an international pharmaceutical company, a major medical device company, and a start-up in the emerging DNA-testing industry.